What Can We Do About Cardiogenic Shock?

Circ Cardiovasc Interv. 2017 Nov;10(11):e006020. doi: 10.1161/CIRCINTERVENTIONS.117.006020.

Authors

Anthony H Gershlick¹, Amerjeet S Banning²

Affiliations

¹ From the Leicester Cardiovascular Biomedical Research Centre, University Hospitals of Leicester, Glenfield Hospital, Leicester, United Kingdom. agershlick@aol.com.
² From the Leicester Cardiovascular Biomedical Research Centre, University Hospitals of Leicester, Glenfield Hospital, Leicester, United Kingdom.

PMID: 29146673
DOI: 10.1161/CIRCINTERVENTIONS.117.006020

No abstract available

Keywords: Editorials; acute coronary syndrome; coronary occlusion; heart rate; shock, cardiogenic; tocilizumab.

Publication types

Editorial
Comment

MeSH terms

Humans
Percutaneous Coronary Intervention*
ST Elevation Myocardial Infarction*
Shock, Cardiogenic